Batteries one of these Testing. So, make sure it's picking the body here. Testing, one, two, three, there. Three batteries should be okay? Yeah, yeah, should be. Let's take this out of you. Should good. Okay. Let's Batteries in this too? Do you think you would want this monitor on? I didn't ask him about it. I didn't ask. Okay. I can. Yes. Okay. Is recording Yes recording. Do you want to have the chat? Turn on because if you turn it on now, we can close the window, but if someone turns it on a Stop letting me sign on in two places. A, What would you like for lunch? If you want. They're all sandwich have one wrap water? Yeah. Okay. Oh, right. I had a chance you want to get the.Exce so we have this monitor here that kind of shows you your notes and everything and also the next slide. Okay. Do you want to turn it off Okay. I switch off. Sometimes we don't turn it on, but we can. Yeah, it's nice. All right, you have everything you good luck. Er. Thank you. Good? Okay. I didn't see it doesn't do that anymore. There. I like to do that that one this is. I can't log on in two places anymore. So I have to use a different email address to log. Okay. Okay. But I need to be able to chat with. Okay. I should just set that up. Yeah, I should add start to take this over. Oh, but you know you can tell him not to. So when you join, just say you want to switch justTanks Microphone for that instruction. I don't have to. Okay. Yeah. Yeah, part of that. So one of the questions came up with it? Does that mean to So Yeah, I'll highlight. Yeah. Yeah, I awesome to share back. Yeah. No, they have yeah. 30 years ago. Hi, I'm Thank you. In. I give the grand. During COVID it's popular now, I think. Kind of freaking out. I was like, I kind of expected yeah, I'm glad I said. Although I sent west. Your advisor was two No, no, so if I'm adding Sam as my, by two more only two con Simon yeah. Yeah. I'm going to ask and what that might look like. 2001, they did there. Yeah, yeah. I think that should have ended. I should Yeah. Yeah. Yeah, that's what I was talking about dedicated to learning. Yeah. So you have the interest as far as sellex systems or behavior. Yeah, I think. So go. I'm glad you made it. Okay. Okay. Yeah. I so I've been able to enter by the signs. I was like, myself, we're going to be but Oh. I hope you all but this is so weak. No like this only happened for the for 110 years. So my family really enjoyed it. I hope you get more cv. So it's really a great honor to have doctor Sim Jung down here with us today. Doctor Dong earned his bachelor degree in chemistry from Holy Crowd College and went on to complete his PhD with doctor Larry Diversity at UCLA. So doctor Dong his post of training with doctor David Anderson at Cal high. Um, Bob John currently is now a professor in neuroscience, neurosurgery and dermatology at Johns Hopkins University. So he received HHMI young Investigator of 2009 and became an HHII investigator in Anti psychology. His research has identified a family of de protein coupled receptors that regulate pain and each sensation, which has led to the development of normal tech compound clinical time. It also. Almost every coastal like I start and I will latch I'm looking forward to hear about this first I want to pen Thank you very much for the nice introduction and thank you for coming to my talk, and it's always the best feeling to see the former Tinse achieve great success like Leon. And so happy New Year, everyone. And so today, I'm going to talk about this GPCR family. I cloned when I was a poster and David Anderson left and sorry. Down. Freeze here. Yeah, I think you put in there. Volunteer. Yeah. Okay, maybe I just do manually then. Okay, now it works. Yeah. Okay. Great. So sorry for the glitches. And so the RG include large family DPCR and there are 50 mouth Rgs shown here in family and 18 human Rgs. And the interesting thing about this family is on evolved very recently is only evolved in the tetrapod, the animal with four limbs. Now it makes sense because only the animal with four limbs can scratch their edge. And so they don't exist in my fish, actually. So here, most of the MRGs are clustered on the mouse chromosome seven, human chromosome 11. I show the gene cluster here and each bar represent one RG. And the RG will first identify in sensory neuron and later on, found in other immune cells like mass cell, neutrophil and basophil. And based on the sequence, based on the expression pattern and also the vegan specificity, we can assign different human homolog shown here. So this gene family, as shown here, expressing diverse cell types, and I have a different biological functions. So let me tell you the story on this receptor as each receptor first. So what is H? H is defined by this German physician more than 360 years ago as unpleasant sensation to make you want to scratch. And although it's a very simple definition, but it's still accurate, so we currently still use it. But why do we need H? So H is considered as a protective mechanism just like a pain, and you want to scratch to remove irritant from the skins. And other people think scratching can actually mobilize immune cells in the skin, so you have more immune response, and also it can call our attention to the affected skin areas and avoid irritant in the future. And also the scratching can really provide temporary relief, so you feel good, so that's why you're scratching. However, the pathological chronic it can lead distress and suffering doesn't have much beneficial value for chronic itch. So the work from Mylab and many other lab now show that each is a distinct sensation from pain sensation. And also the beautiful work from Leons while she was a poster in MLf and showed there's each specific neuron in dorsal root ganglions. And, we also find the MRGs the receptor with clone. Some of them actually expressing dorsal root galleon sensory neuron, and these are the neurons and axon to the skin. And some of these RG is function as a novel H receptor mediating non chimergic age, just give you an example. So this receptor is called MRGD. It's a receptor for beta onin. So if you do body building, you probably heard of beta onin because the body builder tend to take a lot of uh beta one and other supplement to build muscles. And, however, they all experience very strong itch as a side effect. It turned out this beta on combines MRDD to generate this irritating itch sensation. And besides those acute itch, when the itch lasts longer than like four or five weeks, it becomes chronic, and that's a disease state. And as you know, many skin disease like acma and psoriasis or different type of dermatitis can also cause chronic itch. And then the systemic disease like liver disease or kidney disease can also accumulate a lot of metabolite in the system to cause chronic itch. And drugs induce side effects, each side effect is also a big problem like morphine ng morphine can cause a lot of itch. Uh, also, there's a neurological neuropathic age like shingles and so then this over 2000 years ago, the Greek physician made a striking notice, and they found a lot of yellow skinned people tend to complain intensive itch. Now we know this condition is called jaundice. So the jaundice is actually caused by accumulation of the yellow metabolite called Blrubin in the system. And the Blrubin is a degradation product from him. And normally it can excrete it in the urine and feces. And, however, if you have a liver damage and this secretion passes block, the bilirubin can accumulate a very high level to cause yellow skin and also cause itch sensation. And so basically the jaundice associate itch commonly occurred in the context of liver damage, like clostsis like the blockage and stoppage of the bile flows. And so this costsis can cause by many different liver injuries. And many people in the US actually suffer from this condition. However, currently, there's no effective treatment for closty itch. So when a talented former MD PhD student Jimmy entered the lab, he wanted to know why or how Billy Rubin can cause it. So First of all, I just tell you how do we study itch in mice, and it turned out very simple. We just inject whatever itchy chemicals into the back of the skin in the neck, in the mice and like his tomy or Bilirubin, you can watch them for record them for half hour, as you can see here, the mice actually can elicit this characteristic scratching behavior using the hind paw and scratch at high frequency, about ten hertz. So you can just videotape for 30 minutes and count how many times they scratch and quantify that. And, so Jimmy actually did the experiment, so he inject Blrubinto the mole skin and increase dose, you can see here, Bilirrubin can induce dose dependent scratching behavior in Wild time mice shown here. And he also pre treated the mice with antihiamin. However, the antihamine did not reduce Billy Rubin induced age. So suggesting that Bilirubin cause non homergic itch. And then he wanted to know whether there is a bilirubin receptor existing mouse genome. So he actually screened all the mouse Rgs and human Rgs against bilirubin and using the standard calcin imaging as a read off for GPCRs. As you can see here, he found mouse MRG A one and human genes called MRGX four and show a pretty nice dose response curve In response to a Bilirubin stimulation consistently. And we also did a binding essay, and we found Bilirubin can directly binds to these two receptors at the EC 50 around the micromolar range. So this is the range you can find in the colostic patients. And it turned out most of the MRGs are low affinity. So the micromolar is 50 or low affinity and broadly tuned receptor. So later on, three D structure actually can show why this receptor are low affinity and broadly tuned. So then Jimmy Fund, this receptor is also specifically expressed in a subset of DRG neurons as shown as a green staining here. And then he also tried to see whether Bilirubin can really excite the neuron by using patch claim recording. As you can see here, Bilirubin can induce very robust action potential in the wildtype DRG neuron. However, if you apply Bilirubin into the MGA one, knockout DRG neuron, there's no activation at all. And consistently, if you just inject the BDI Rubin into the MGA one knockout new mice, you see the BDI rubin this scratching are significantly reduced. So suggesting the MGA one mediate BDI rubind edge. So those are the injecting the exogenous bilirubin. Here, Jimmy actually developed a colocated model for mice. So he actually used a chemical to damage the liver to block the excretion of Brubin. So as you can see here, after those liver damage or this colossus condition, there is a significant increase in the bilirubin level in the mice in both wild type and MRG knockout mice. However, these mice actually can develop a spontaneous scratching because accumulation of Dlubin presumably. You can see the Wilt mice after the liver damage, they scratch significantly higher than the control mice. And however, the MRGA one mice scratch much lower than the Wilt mice. Again, this data suggests the MRGA one actually mediate lostatic itch. And then we collaborate with physicians actually collect the serum from several lostic patients. So this patient actually suffered very severe itch and their bilirubin level are significantly increased as we measured. And then Jimmy actually can inject this serum either from the healthy controls or from six costic patient individuals into the wildtype and also MRGA one narco mice. And the healthy control serum did not induce significant scratching between wildtype and narco mice. However, for Closytic patient serum, they induce a significant higher scratching compared to the scratching in the MRGAONaco mice. So human phytic serum can cause itch in mice. So then we want to know what's in the serum really cause this itch, right? Is Brubin really the factor? So Jimmy actually, uh, using two different methods to deplete or block the Bilirubin. First of all, he used iron chloride to deplete Bilirubin from the serum. Another approach, he used Bilirubin antibody. In both cases, you can see at the green bar, the scratching are significantly reduced. So if you remove Bilirubin from the serum, you can have much less scratching suggesting that Bilirubin is a major contributor in the serum to cause itch. So here, later on, Jimmy and several other lab showed the human version of this receptor not only binds to bilirubin, but it can also activate another lipid called bio acid. So bio acid has shown to be a major factor for the costed edge. Now we identify a novel bio acid receptor mediate bio acid induced costed g. So just summarize this part of the work. So we found the mouse RG A one, human MgXour a bilirubin receptor, and human RG X four is a bio acid receptor, and they all mediate closeted edge. And so now I want to switch the gear a little bit to talk about other Rgs. We found some other Rgs not expressed in sensory neuron, but rather express in innate immune cells like mass cells, neutral fuel and basal fuels. And so today I will tell you several story about mass cell receptors and also neutro field receptor. And they play an important role in plain H and also host defense. So what is cells? So us cell are the first responder cells upon infection injury. So they are the tissue resident cells. You can find them in the skin in many other tissues. And so the major characteristic of this type of cells are they can when they activate, they can degranulate and release the famous histamine to cause allergic reactions. And they also can release serotonin proteins and cytokines and to recruit other immune cells and promote inflammation. And so there's two major pathway to active ma cell and degraded mas cell. One major pathway is called IGE and FC receptors. So this is antibody IGE and you can have antigen specific IG bind the antigen and cross link the the FC receptor to induce cell degranulation to cause classic allergic reactions. And then there's another major pathway people notice for decades, and that is the pathway activated by the so called pose charge substance collectively called basic secreticGag. So basic means postechart secret gas means make cell to secrete. And there's many positive chart peptides and compounds can activate my cell to degranulate. And however, the receptor is unknown for many years until our discovery. So former poster Benjamin McNeil actually identified these basic security guards. And so he found this MRG B two is exclusively expressed in mouth cells. And so we generate MRGB two cre lines and use did metal to label the MRGB two expressing cells. And we found 100% of this receptor expressed in cells and shown using another marker called evidence. So there's 100% overlap, and you can find these positive cells in many tissue, including skins, airway and heart. And and this is also consistent with online gene chip data. So people find by sequencing that mouse MRGB two are exclusively expressing my cells and not in any other tissue, not in DRG either. And later on, people find the human homologs called RG X two is also specific expressing human cells. So to make a long story short, and Ban actually use multiple approaches and find these basic secudigag shown here can specifically activate these two receptors. For example, compound 48 is most commonly used secreto gag. Degranded cell, it can activate both receptors, and the substance P is a famous neuropeptides. It's also positive charge, can also activate these receptors. And besides the basic security guards, and Ben also found many other drugs can cause anaphylatic reactions shown here, can also activate these receptors, okay? And so these drugs are commonly used in the clinic to treat different kind of conditions. And so what is anaphylatic shock? So this is a relatively common conditions, especially during surgeries, so it can be life threatening, so you can have a very sudden drop in the body temperature and lower blood pressure and short of brightness, breath and can cause by food, venom and medications. So it's pretty serious condition, and to our surprise, all those drugs cause anaphylatic reactions can robustly activate wild type mus cells, and nearly 100% all the muscle responds to those drugs. However, in MRGB two knockout muscle, they don't respond at all. It's very clean result. And you can actually induce anophlatic reaction by tail away injection, one of the antibiotic called separate flaxation. So if you inject tail away inject hydros a very quick shorter time, you can actually see the anophalatic reactions. So here just show the body temperature is dramatically decrease within a few minutes in the wilt mice. And many of these mice actually died because of shock. And then if you look at the knockout, they are fine, so none of them actually killed by these anaphylatic reactions. So this data indicate this muscle specific receptor MIGB two, a mediate drug induced anaphylatic reactions. So why this receptor can have so many ligands and activism? So Brian Ross's lab at UNC and another lab in China, actually, they solve a three D structure of this human receptor MRX two using Crow EM. And they found this binding pet, this receptor has very shallow, so it can fit a lot of ligand into it. So the shallow bending pack fed the ideas from misc receptor, and they also find negative charged residue actually can interact with the positive charged ligands. So basically, their three D structure consolidate with our biology data pretty well. So then we also want to know whether this muscle receptor play a role in pain sensation. So former host Dustin Green want to know whether this receptor, the muscle receptor, have a role in pain or not. So as you know, um substance P is a key neuropeptide mediate a process called neurogenic inflammation. So when you have a tissue injury, the injured nerve actually can secrete neuropeptides like substance P. And then substance P can activate nearby muscells to induce inflammation by secreting cytokine chemokines to recrut other immune cells. So this process called neurogenic inflammation because the inflammation is caused by nerve injuries. Through the substance P release. So the dogma field in the pain field suggests there's a canonical receptor or conventional receptor for substance called pachycinRceptor or K one receptor function as a substance P receptor mediate neurogenic inflammation. However, the antagonist, the clinical trial for the antagonist NK one failed with a very disappointed outcome because they don't have any energetic effect. So what is going on here? Dustin just perform very simple experiment. You want to see whether the K receptor is really expressing muscle or not. As you can see here, the N by using RTPCR he only detect NK one receptor, the carmonic receptor of substance P, only in the spinal cord, but not in the DRG sensory neuron. And more importantly, it's not in mass cells. On the other hand, our receptor MGB two are highly expressed cells, not in DRG, not in the spinal cord. So it is MRGB two, but not K one expressing cells. So consistently, when we apply substance P onto the cell, as you can see here, nearly 100% M cell degranulate, whereas knockout MRGBt knockout mass cell, there's no response at all to substance P. And then besides the degranulation, they also measured the chemokine release. So here, just show you a couple examples of CCL two, CCL three released from cell degranulation, so induced by substance P treatment. So the Wilt M cell release a lot of CCL two and CCL three upon substance P stimulation whereas MRGB two Marcom substance B fail to induce CCL two, CCL three release. And then they also does also inject substance P into the skins and see the immune cells recruitment. So here we use three different group of mice, Wil type mice, the NK one narco mice and MRGB two narco mice. In both WL type and NK one narco mice, and substance P injection into the skin can induce a significant increase on immune cell recruitment like CD 45 positive cells, neutral field recruitment, and also monocyll recruitment in both NK one Naco and wildtype mice. However, in the MRGB two Naco substance P fail to induce immune cell recruitment. So the substance P promote immune cell recruitment through our receptor, but not from this NK one receptor. And then besides injecting just substance P into the skin, Dasin also used this hind paw incision model, which I can show you the actual picture in the next slide. So basically, he just made a small cut into the hind paw and induce injury and the inflammation, and then using flowcytomery to measure the the immune cell recruitment from the tissues from the hind paw. And we Wild time mice, after injury, there's a significant increase of immune cell recruitment, whereas MRGB two narco mice, the recruitment are significantly reduced. So just show you the actual picture here. So this is a incision model, wild type and knockout and hind paw. And so here the picture illustrates this immune injury induced inflammation is very prominent in the wildtype mice, but it's significantly reduced in MRGBt knacko mice and consistently, the injury induced pain sensation. Here we measure the mechanical pain. Also thermal pain has the same phenotype. The ww types show very robust or very severe injury induced pain. Whereas a knockout, the pain is significantly reduced. So suggesting that MRGB to contribute to inflammation and pain. So here just summarize this part of the work. And so upon tissue injury, the sensory nerve can release a lot of neuropeptide like substance P and activate nearby cells through the receptor MRGB two to release chemo cytokine to induce immune cells recruiment and induce neurogenic inflammation and pain. In a parallel study, the former student Jimmy actually also look at the MRG B two in my cell into the nonhomergic age. So as you know, histamine can also cause itch during asthma allergy. And so Jimmy did a side by side comparison between these two major pathways, mall degranuation pathways. And he found upon the allergic reaction pathways, the M cell actually release a lot way more histamine and serotonin on the other hand, if you activate this muscle with MLGB two pathways, they release less histamine serotonin, but more tryptase, and they actually activate different set of sensory nerve nearby so to induce non hm alergic H. So now I want to switch gear to talk about another biology we just discovered. So we found a defensin receptor in neutro field, which can prevent skin dysbiosis and bacterial infection. And this work is done by a form of poster syntod and so what is defensing? So the defensing are the antimicrobial peptidees first identified from frog skin in 1987. So defensing is very important for us, actually. I can directly kill the invading bacteria and fungi. And there are more than 50 defensive peptidees in human mice. And it's expressing the skins also on GI tract. And so they can directly kill the bacteria because they can form this helix loop helix and then insert into the negative charged bacterial cell wall to make a hole to kill the bacteria. So people actually can design antibiotics based on the structure of defensings. And however, due to the gene redundancy, because there's 50 of them and genetic tools, the vivo mechanism of defensing action is not unclear. But especially we don't know whether defensin besides can directly kill the bacteria, can they actually also signaling our whole cells? If that's the case, what's a wholesale receptor? For defensins is unknown. So how to really solve this problem, there's 50 defensin genes in the genome, but they all clustered on the mouse chromosome eight. So Symptom actually take effort to make a conditional knockout line but introduce lake psite into each end of the defensin cluster. And so this process take about two years. So it's very long process, and it turned out really well. So it actually worked. So by introducing the lax P site into at the end of each end of the defensive gene cluster, and then she crossed with a Caratinosize, specific cree called K 14 cree, and then actually the deletion works, that's pretty amazing. So we can delete all 3 million base pair altogether, about 50 defenses altogether. Showing the genomic PCR show the whole cluster actually deleted, so you can have this PCR product made. And then she also look at the MRA for defensing. So here, she use control wild type skins or the wild type skin infected with stepors bacteria or Assay. You can see after infection, there's a strong induction of defensing expression. However, in the defensive cluster narco mice, the defensing expression is completely gone. So here just show the immuno staining of the defensins. And so she used antibody to look at the defensins. So without infection, there's not much defensing expression. After the Steph Os infection, and you can see it turned on. And however, in the defensins knockout skins, there's not much de peptie expression at all. And to make a long way short and Xintong also identified another MRG member called MRGA two is defensing receptor and specifically expressing a neutral field. Here she just used RScope the red signal to look at the MRGA two expression and use six G as a marker for neutral fields. And she found about 40% of neutral field wildtype Well ti mice show this the MGA two expression in neutral field. However, in the MGA two knockout mice, the neutral field expression is completely gone. Okay. Then she also did a neutral field degranulation say essay for this Elastics release, and she found defenses can induce those response, uh, elastics release from neutrophil in the wilt neutropel. However, in MGA two knockout neutro field, the elastics release is completely eliminated. So suggesting the MRgA two is a defensive receptor expressing neutral field. So a healthy skin can maintain a balance and diverse microbiome on their skins, which can prevent bacterial infection. However, if you have any pathological disturbance, they will lead to outgrowth of pathogenic bacteria at the expense of other diverse camoslls. So here, a uh, into actually perform this 16 S ribosomal RA sequencing for the bacteria on the naive skins, comparing the wildtype, the defensingnac, and also the defensive receptor HA two narc skins. Uh She found on the wildtype skin, naive skins, the diversity of bacteria is very high, whereas in the narcot skins, the diversity of the microbiome is significantly reduced. And then look at the individual bacteria strength uh uh, she found in the Wild time mice skins, there's a very diverse and balanced the bacteria, different type of bacteria. However, in the knockout, there's expansion of pathogenic bacteria. For example, this green one, Staph locus is way expanded compared to the uh wildty mice. Suggesting without this receptor or defensing and the mice has this biosis. So the bacteria composition is totally changed. And uh and beside the naive skin, and symptom also infected the skin by the exogenous Sephoris so she can either paint the bacteria onto the skin or inject the bacteria onto the skin, either wild type or the receptor narcot or the defensive narcot. And in the wild type skin, you can see the lesion sites cause bacteria. And also the bacterial load in the wildtype are significantly lower than the kakout animals many days after the infection. So here, just show the examples, the represented images. So as you can see here, the knockout after the injection, the bacteria lesion site is a lot bigger than the wildtype mice, whereas using the bio luminescence imaging we found after the infection, both knockout showed a significant higher bacterial load compared to the wilti mice. So this data indicate without defens or without defensing receptor, the skin cannot fight well with a bacterial infection, so you have a way severe infection afterwards. So one of the hallmark of the sporis infection is forming this neutral field absence. So here, Symptom did the skin histology 24 hour after the stporis infection. So in the Wilt mice and knockout and she used gran staining to look at the bacteria shown here. And then for the LG to look at the neutral field cells. And as you can see here, in the Wilt mice after stephors infection, the bacteria actually confined in a small region and surrounded by neutral field. So actually neutro field actually attack the bacteria to confine them into this abscess. However, in both defensive knockout or the receptor knockout, there's not much neutro aggregation, and the bacteria actually spread in a large area. So that's why you have a larger the larger lesion size shown here, higher bacteria load. And here just show the quantification of neutral field recruitment. And you can see here, Wilt mice has a lot of way more neutral fuel recruitment where after the infection, whereas in the knockout, the neutro field recruitment is significantly reduced. So both defensing and receptor really mediate neutral field recruitment and abscess formation. So mechanistically, we found after the bacterial skin infection, the neutro f actually can release cytokines, chemokines. Here, we just show you three different examples like one Beta, CXCL one or two, and we found both in the nac in the wildtype after infection, all these, chemokine cytokine are significantly increased release by the neutral field. And then the narco those narco the cytokine chemokine release are significantly reduced, and so they mediate the cytokine and the chemokine release. So here, just summarize this part of the work. So we think in healthy skin, there's a low level of defenses level of defensing and they actually keep this diverse and balanced microbiome maintained on the skin on the healthy skins. And there's also some skin resin neutrophil, keep the healthy skin intact. However, after the bacteria infection, and this balance is disturbed, and then there's upregulation of defensing increased. And then they actually activate skin residn neutropel through the MRGA two receptor, and they release a Uh, interlooking one Beta or CX one or two, and they can recruit more neutrophil infiltrate into the area to form this neutrophil abscess to confine the bacterial infection. So without the defensing and without the receptor, and this process is disturbed, and then you have way worse infections. So here, I just want to show you what we're going to do next. So as I mentioned, we found a muscle receptor, specific receptor, and its function receptor for many neuropeptides like substance P and play important role in the neurogen inflammation and paan H. And now we are working on the role of the receptor or lls in the ischemic stroke, uh and also in the fibromyalgia pain and multiple sclerosis. So right now we are using again, using mouse model for this disease to look at the muscle and muscle receptor. And hopefully in the future, we can develop a small molecule antagonist blockers to treat many of the disease. In fact, the phase two clinical trials is going on right now to testing some of these conditions using the MRGX two antagonist. And for the MRG A two, uh, project. So again, this is a defensin receptor, and now we are moving into the brain to look at the brain infection like meningitis and see whether defensin play a role there. And also, we want to know whether the defensins and MRgA to play a role in psoriasis. Is a condition where you can see a strong ab regulation of defenses in the psoriasis. So as mentioned, this receptor play a diverse role in many basic biological process and also disease from pain, ache and innate immunity. And so we only dorphanize half of this gene family, and still many of them, we don't have clue. We don't know where the expression and the ligand, so there's still a long way to go. And thank you very much for your attention. So here is the people who have done all the works. Thank you. Pricing. Yeah. And plastic word thank you. Two related questions. Yeah. Sorry if I missed this. But given that X four can respond to bilirubin as well as bile acids. What is the evolutiary advantage to inducing a niche response to when there's, like, liver distress? Yeah, so we don't know whether this receptor have any physiological roles, right? So recently, we published a paper showing this also receptor for fossil group. So we identified many fossil group drugs can activate this receptor. It turned out adding fossil group is a common way to in drug development to induce water solubility. So people are actually adding intentionally adding phos group into difficult drugs to dissolve in water, but at the same time, they each a a side effect. So we found those each side effect actually caused by this receptor also. And uh but from that, we actually find some other lipid indgent lipid phospholipid like geno diphosphate can activate this receptor at a very low EC 50, like nanomolar range. So maybe that can give us some hint whether this receptor can sensing more indulgent phospholipid or something. So we are working on that. Yeah. Yeah. Yeah, go ahead. Do you have second question or you sort of answered it, the neurons that Express por are they known to respond to any other stimulus. So it seems like they're Yeah. Thank you. Go ahead. Maybe same point. From your data is though the Billy Rubin neurons Billy Rubin are multimodal. Yeah. So I'm wondering if you looked at other ligands in terms of what else might act? Yeah, so these neurons can activate bilirubin bio acid, some other itchy substance. And in mice, it turned out there's three different itchy sensing neurons, and they called NP sorry P one, NP two, MP three. And so in mice, there's a small subset of each neurons. However, in human is a little bit complicated. Maybe they are more converge into the one large subset and one neuron can respond to multiple itchy substance. That's possible, too. And somehow the mice has, like, more dedicated each neuron now. It seems that those neurons primary sensory neurons be mechanical sensor. Too. Yeah, yeah, they do express PSO, but people actually in mice, at least, identify mechanical sensitive neuron, too, mechanical sensitive mechanical H neuron, actually, yeah. Yeah, yeah. Yeah, go ahead. So, I mean, first off, thank you for coming to speak with us. Yeah. I learned a lot. I'm kind of curious. I know at the end you touched on antagonists for MRD for fibromyalgia. Yeah. Two, sorry, VT. Yeah. So I'm kind of curious. Do you think there's, like, a hyperepression going on in those patients or what? Yeah, so the so this receptor recall is called MRgX B two, sorry, for the mass cells. And as I show you at the RTPCR, the receptor is already expressed very high level in those cells. And we don't think the expression in particular cell going to go up. And more because they're already very high expressing genes. So maybe the number of new mall can increase or they aggregate, that's possible. Yeah. People actually has the data showing the fibromyalgia. We have our collaborator have poplic data showing the fibromyalgia patients skins actually has a lot of mass aggregates. So yeah, so there's many companies working on this receptor and tagons right now. Yeah. Thanks for the great talk. I was curious about the defensive. Yeah. Here what cell type they're coming from? I think they're signaling to the neutrophils, is that right? Yeah. So basically, we show there's two actions. Other people show there's a direct killing action to the bacteria, but now we show they can activate the neutral field. And they mainly from the keratino site. So that's Beta defens. There's also Alpha defens. Alpha defenses is more in GI track. They are made a different type of cells. And so we found actually the Mina cells also make defensins. So that's why we are looking at ndagitis right now. Yeah. Any other questions? Yeah. Thank you.